Published in PLoS Med on October 16, 2007
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration. PLoS Med (2012) 3.62
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement. PLoS Med (2015) 2.72
Supervised and unsupervised self-testing for HIV in high- and low-risk populations: a systematic review. PLoS Med (2013) 2.69
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med (2011) 2.68
Body mass index categories in observational studies of weight and risk of death. Am J Epidemiol (2014) 2.62
Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals. PLoS One (2012) 2.55
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39
Predicting ADL disability in community-dwelling elderly people using physical frailty indicators: a systematic review. BMC Geriatr (2011) 2.21
Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am J Epidemiol (2012) 2.07
Incidence of sudden unexpected death in nocturnal frontal lobe epilepsy: a cohort study. Sleep Med (2014) 2.00
How successful are current ankle replacements?: a systematic review of the literature. Clin Orthop Relat Res (2009) 2.00
How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav (2014) 1.93
Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med (2011) 1.89
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. BMC Med (2012) 1.85
STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest (2009) 1.82
Tweeting the meeting: an in-depth analysis of Twitter activity at Kidney Week 2011. PLoS One (2012) 1.82
Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours. Emerg Themes Epidemiol (2008) 1.74
Observational studies: getting clear about transparency. PLoS Med (2014) 1.64
Toxicology and epidemiology: improving the science with a framework for combining toxicological and epidemiological evidence to establish causal inference. Toxicol Sci (2011) 1.64
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS Med (2015) 1.61
Attitudes and Acceptability on HIV Self-testing Among Key Populations: A Literature Review. AIDS Behav (2015) 1.52
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet (2009) 1.47
Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosis. Clin J Am Soc Nephrol (2011) 1.46
STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement. PLoS Med (2011) 1.42
Increasing live birth rate by preimplantation genetic screening of pooled polar bodies using array comparative genomic hybridization. PLoS One (2015) 1.41
Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review. BMJ (2014) 1.41
Anatomy of the epidemiological literature on the 2003 SARS outbreaks in Hong Kong and Toronto: a time-stratified review. PLoS Med (2010) 1.31
On the plurality of (methodological) worlds: estimating the analytic flexibility of FMRI experiments. Front Neurosci (2012) 1.31
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Ann Rheum Dis (2009) 1.30
Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nat Rev Endocrinol (2011) 1.29
Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: "STROBE-RDS" statement. J Clin Epidemiol (2015) 1.25
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol (2009) 1.25
Quality of Cohort Studies Reporting Post the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement. Epidemiol Health (2011) 1.22
Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol (2012) 1.21
Setting the RECORD straight: developing a guideline for the REporting of studies Conducted using Observational Routinely collected Data. Clin Epidemiol (2013) 1.19
Exposure to general anesthesia and risk of Alzheimer's disease: a systematic review and meta-analysis. BMC Geriatr (2011) 1.16
Gestational diabetes mellitus in Africa: a systematic review. PLoS One (2014) 1.15
Managing depression in primary care: A meta-synthesis of qualitative and quantitative research from the UK to identify barriers and facilitators. BMC Fam Pract (2011) 1.14
Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis. PLoS One (2015) 1.14
Epidemiology of glaucoma in sub-saharan Africa: prevalence, incidence and risk factors. Middle East Afr J Ophthalmol (2013) 1.10
Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement. PLoS Med (2011) 1.09
Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life. PeerJ (2013) 1.08
Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Epidemiol (2011) 1.04
Increasing the use of skilled health personnel where traditional birth attendants were providers of childbirth care: a systematic review. PLoS One (2012) 1.03
Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria. J Acquir Immune Defic Syndr (2014) 1.03
Cementless total hip arthroplasty in rheumatoid arthritis: a systematic review of the literature. Arch Orthop Trauma Surg (2011) 1.02
Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA). Eur J Clin Pharmacol (2014) 1.02
How to write a scientific manuscript for publication. Blood Transfus (2012) 1.02
A prospective observational study of quality of diabetes care in a shared care setting: trends and age differences (ZODIAC-19). BMJ Open (2012) 1.01
The prevalence of primary angle closure glaucoma in adult Asians: a systematic review and meta-analysis. PLoS One (2014) 1.01
Clinically unapparent infantile thiamin deficiency in Vientiane, Laos. PLoS Negl Trop Dis (2011) 1.00
Scientific rigor and the art of motorcycle maintenance. Nat Biotechnol (2014) 1.00
Meta-analyses of the 5-HTTLPR polymorphisms and post-traumatic stress disorder. PLoS One (2013) 0.99
Use of causal language in observational studies of obesity and nutrition. Obes Facts (2010) 0.97
Recommendations for third molar removal: a practice-based cohort study. Am J Public Health (2014) 0.97
Better reporting, better research: guidelines and guidance in PLoS Medicine. PLoS Med (2008) 0.96
Atrazine and breast cancer: a framework assessment of the toxicological and epidemiological evidence. Toxicol Sci (2011) 0.95
The value of body weight measurement to assess dehydration in children. PLoS One (2013) 0.95
Impact of STROBE statement publication on quality of observational study reporting: interrupted time series versus before-after analysis. PLoS One (2013) 0.95
Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis. PLoS One (2013) 0.94
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Epidemiol (2011) 0.94
Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling. Cancer Epidemiol Biomarkers Prev (2012) 0.94
Proceedings of the second international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control (2015) 0.94
Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort study. PLoS One (2013) 0.93
Variations and inter-relationship in outcome from emergency admissions in England: a retrospective analysis of Hospital Episode Statistics from 2005-2010. BMC Health Serv Res (2014) 0.93
Translation, cross-cultural adaptation and validation of the Danish version of the Oxford hip score: Assessed against generic and disease-specific questionnaires. Bone Joint Res (2012) 0.93
EQUATOR: reporting guidelines for health research. Open Med (2008) 0.91
Evaluations of reproductive health programs in humanitarian settings: a systematic review. Confl Health (2015) 0.91
Research across the disciplines: a road map for quality criteria in empirical ethics research. BMC Med Ethics (2014) 0.90
Worksite health promotion in six varied US sites: beta testing as a needed translational step. J Environ Public Health (2011) 0.90
Relative survival: a useful tool to assess generalisability in longitudinal studies of health in older persons. Emerg Themes Epidemiol (2011) 0.90
Does maternal body mass index during pregnancy influence risk of schizophrenia in the adult offspring? Obes Rev (2011) 0.90
Better reporting of scientific studies: why it matters. PLoS Med (2013) 0.90
Prevalence of high blood pressure in 122,053 adolescents: a systematic review and meta-regression. Medicine (Baltimore) (2014) 0.89
HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007. Retrovirology (2010) 0.89
Earth Observation, Spatial Data Quality, and Neglected Tropical Diseases. PLoS Negl Trop Dis (2015) 0.88
Surgery-induced changes and early recovery of hip-muscle strength, leg-press power, and functional performance after fast-track total hip arthroplasty: a prospective cohort study. PLoS One (2013) 0.88
From Checklists to Tools: Lowering the Barrier to Better Research Reporting. PLoS Med (2015) 0.88
Adherence to granulocyte-colony stimulating factor (G-CSF) guidelines to reduce the incidence of febrile neutropenia after chemotherapy-a representative sample survey in Germany. Support Care Cancer (2015) 0.88
Risk factors associated with recurrent diarrheal illnesses among children in Kabul, Afghanistan: a prospective cohort study. PLoS One (2015) 0.88
Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. BMJ (2011) 0.87
The Impact of Water, Sanitation and Hygiene Interventions to Control Cholera: A Systematic Review. PLoS One (2015) 0.86
The reporting of studies using routinely collected health data was often insufficient. J Clin Epidemiol (2016) 0.86
Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis. PLoS One (2016) 0.85
Disciplined doctors: does the sex of a doctor matter? A cross-sectional study examining the association between a doctor's sex and receiving sanctions against their medical registration. BMJ Open (2014) 0.85
Worksite wellness program implementation: a model of translational effectiveness. Transl Behav Med (2012) 0.85
HTLV-1 and HIV-2 infection are associated with increased mortality in a rural West African community. PLoS One (2011) 0.85
Comparison of Arbekacin and Vancomycin in Treatment of Chronic Suppurative Otitis Media by Methicillin Resistant Staphylococcus aureus. J Korean Med Sci (2015) 0.85
Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study. PLoS One (2013) 0.85
The prevalence of malocclusion and oral habits among 5-7-year-old children. Med Sci Monit (2014) 0.84
A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr (2016) 0.84
STrengthening the reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. Eur J Epidemiol (2011) 0.84
Risk Factors for Development of Septic Shock in Patients with Urinary Tract Infection. Biomed Res Int (2015) 0.84
A checklist to improve reporting of group-based behaviour-change interventions. BMC Public Health (2015) 0.84
Phase II evaluation of sensitivity and specificity of PCR and NASBA followed by oligochromatography for diagnosis of human African trypanosomiasis in clinical samples from D.R. Congo and Uganda. PLoS Negl Trop Dis (2010) 0.84
Relationship between altitude and the prevalence of hypertension in Tibet: a systematic review. Heart (2015) 0.83
Living with cat and dog increases vaginal colonization with E. coli in pregnant women. PLoS One (2012) 0.83
Patterns of injection drug use cessation during an expansion of syringe exchange services in a Canadian setting. Drug Alcohol Depend (2013) 0.83
Prevalence and predictors of antibiotic administration during pregnancy and birth. PLoS One (2013) 0.83
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet (1999) 37.76
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet (2001) 31.74
Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ (2001) 20.65
Why we need observational studies to evaluate the effectiveness of health care. BMJ (1996) 17.27
CONSORT statement: extension to cluster randomised trials. BMJ (2004) 16.50
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA (2006) 11.87
Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med (2003) 8.58
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med (2007) 7.87
Value of flow diagrams in reports of randomized controlled trials. JAMA (2001) 7.06
Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol (2007) 7.00
Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med (2006) 6.34
Spurious precision? Meta-analysis of observational studies. BMJ (1998) 5.45
Quality of reporting of observational longitudinal research. Am J Epidemiol (2005) 5.25
Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ (2004) 4.69
What is newsworthy? Longitudinal study of the reporting of medical research in two British newspapers. BMJ (2002) 4.05
Assessing the quality of research. BMJ (2004) 3.90
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Clinical epidemiological quality in molecular genetic research: the need for methodological standards. JAMA (1999) 3.07
CONSORT revised--improving the reporting of randomized trials. JAMA (2001) 2.63
Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies. CMAJ (2006) 2.40
Bias in psychiatric case-control studies: literature survey. Br J Psychiatry (2007) 1.83
Guidelines for documentation of epidemiologic studies. Epidemiology Work Group of the Interagency Regulatory Liaison Group. Am J Epidemiol (1981) 1.79
Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond. CMAJ (2004) 1.77
CONSORT your submissions: an update for authors. Br J Dermatol (2001) 1.64
Suggestions for improving the reporting of clinical research: the role of narrative. Ann Emerg Med (2005) 1.63
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (2009) 34.99
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet (2006) 31.79
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol (2010) 27.58
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA (2004) 23.87
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol (2009) 17.92
Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol (2010) 17.30
CONSORT statement: extension to cluster randomised trials. BMJ (2004) 16.50
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med (2010) 16.11
Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52
Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med (2010) 14.43
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol (2008) 14.36
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87
Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One (2008) 13.32
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (2010) 12.98
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA (2006) 11.87
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80
Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS (2009) 11.62
Epidemiology and reporting characteristics of systematic reviews. PLoS Med (2007) 11.51
Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (2008) 11.08
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ (2004) 10.75
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43
Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet (2004) 9.88
Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst (2005) 9.38
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med (2010) 9.30
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med (2007) 8.77
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet (2004) 8.77
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ (2008) 8.70
Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One (2009) 8.58
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet (2009) 8.54
Developing core outcome sets for clinical trials: issues to consider. Trials (2012) 8.39
Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ (2009) 8.31
Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med (2006) 8.25
SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21
Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet (2005) 7.89
Comparison of registered and published primary outcomes in randomized controlled trials. JAMA (2009) 7.89
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med (2007) 7.87
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol (2009) 7.86
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis. N Engl J Med (2007) 7.86
Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum (2004) 7.79
Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PLoS One (2009) 7.60
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (2014) 7.55
Consort 2010 statement: extension to cluster randomised trials. BMJ (2012) 7.47
Guidance for developers of health research reporting guidelines. PLoS Med (2010) 7.43